Education
About Us
Working with TipRanks
Follow Us
Journey Medical Corp (DERM)
NASDAQ:DERM
DERM Stock Chart & Stats
Day’s Range― - ―
52-Week Range$3.20 - $6.89
Previous CloseN/A
Volume25.59K
Average Volume (3M)58.77K
Market Cap
$141.17M
Enterprise Value$92.02M
Total Cash (Recent Filing)$104.98M
Total Debt (Recent Filing)$313.79M
Price to Earnings (P/E)―
Beta0.54
Next Earnings
May 13, 2025EPS Estimate
-0.24Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.74
Shares Outstanding17,104,437
10 Day Avg. Volume74,223
30 Day Avg. Volume58,767
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.08
Price to Cash Flow (P/CF)-25.90
P/FCF Ratio0.00
Enterprise Value/Market Cap0.65
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit1.75
Enterprise Value/Ebitda-7.10
Forecast
1Y Price Target
$9.88Price Target Upside61.70% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
---
Journey Medical Corp News
PremiumCompany Announcements
Journey Medical’s Earnings Call Highlights MROSI Launch and Growth Potential
PremiumCompany Announcements
Journey Medical Corporation Reports 2024 Financial Results
---
Bulls Say, Bears Say
Bulls Say
Market PositioningDFD-29 is expected to be well-positioned to drive substantial long-term growth based on its superior data compared to Oracea.
Product LaunchThe company expects a full commercial launch in early April, following the availability of the launch product and a national sales meeting.
Bears Say
Stock PerformanceShares have traded down 14% since the product’s approval in November and are now valued at a 55% discount to peers on a 2026 EV/revenue basis.
---
Ownership Overview
44.17% Insiders
2.81% Mutual Funds
14.51% Other Institutional Investors
36.09% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
DERM FAQ
What was Journey Medical Corp’s price range in the past 12 months?
Journey Medical Corp lowest stock price was $3.20 and its highest was $6.89 in the past 12 months.
What is Journey Medical Corp’s market cap?
Journey Medical Corp’s market cap is $141.17M.
When is Journey Medical Corp’s upcoming earnings report date?
Journey Medical Corp’s upcoming earnings report date is May 13, 2025 which is in 43 days.
How were Journey Medical Corp’s earnings last quarter?
Journey Medical Corp released its earnings results on Mar 26, 2025. The company reported $0.1 earnings per share for the quarter, beating the consensus estimate of -$0.198 by $0.298.
Is Journey Medical Corp overvalued?
According to Wall Street analysts Journey Medical Corp’s price is currently Undervalued.
Does Journey Medical Corp pay dividends?
Journey Medical Corp does not currently pay dividends.
What is Journey Medical Corp’s EPS estimate?
Journey Medical Corp’s EPS estimate is -0.24.
How many shares outstanding does Journey Medical Corp have?
Journey Medical Corp has 17,104,437 shares outstanding.
What happened to Journey Medical Corp’s price movement after its last earnings report?
Journey Medical Corp reported an EPS of $0.1 in its last earnings report, beating expectations of -$0.198. Following the earnings report the stock price went down -3.583%.
Which hedge fund is a major shareholder of Journey Medical Corp?
Among the largest hedge funds holding Journey Medical Corp’s share is Royce & Associates LLC. It holds Journey Medical Corp’s shares valued at 0.
---
Journey Medical Corp Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$9.88 (61.70% Upside)
$9.88 (61.70% Upside)
Hedge Fund Trend
Decreased
By 12.7K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $818.1K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 3.5%
Last 30 Days ▲ 0.2%
Last 30 Days ▲ 0.2%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
66.03%
12-Months-Change
Fundamentals
Return on Equity
-72.60%
Trailing 12-Months
Asset Growth
4.41%
Trailing 12-Months
Company Description
Journey Medical Corp
Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant acne; Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; Ximino, an oral minocycline drug for the treatment of moderate to severe acne; and Exelderm cream and solution for topical use. It also sells doxycycline hyclate tablets, minocycline hydrocholoride capsules, and sulconazole nitrate cream and solution. The company was formerly known as Coronado Dermatology, Inc. and changed its name to Journey Medical Corporation. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.
---
DERM Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a positive sentiment with significant achievements, including the FDA approval and upcoming launch of MROSI, positive EBITDA, and a strong cash position. However, there are challenges with decreased revenue from legacy products and increased R&D expenses. The sentiment is buoyed by the transformational potential of MROSI and its expected market impact.Read More>---
DERM Stock 12 Month Forecast
Average Price Target
$9.88
▲(61.70% Upside)
Technical Analysis
Best Analysts Covering DERM
1 Year
1 Year Success Rate
6/9 ratings generated profit
1 Year Average Return
+21.87%
reiterated a buy rating 4 days ago
Copying Scott Henry's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +21.87% per trade.
---